If this proves to be the case, we suggest that early screening for prodromal PD could involve an initial plasma evaluation for elevated B cell lymphocyte Kv1.3 expression which could be followed up with 18F-DOPA PET imaging to examine dopamine signaling functionality. This evidence concerns the gene KCNA3 and Parkinson disease.